Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Du Yan, S.
Right arrow Articles by Stern, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Du Yan, S.
Right arrow Articles by Stern, D. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 4, 2145-2156, January 22, 1999

Role of ERAB/L-3-Hydroxyacyl-coenzyme A Dehydrogenase Type II Activity in Abeta -induced Cytotoxicity

Shi Du Yan, Yigong Shi§, Aiping Zhu, Jin Fu, Huaijie Zhu, Yucui Zhu, Lenneen Gibson, Eric Stern, Kate Collison, Futwan Al-Mohanna, Satoshi Ogawaparallel , Alex Roher**, Steven G. ClarkeDagger Dagger , and David M. Stern

From the Departments of Pathology, Physiology and Surgery, College of Physicians and Surgeons of Columbia University, New York, New York 10032, the  King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia, the parallel  Department of Anatomy and Neuroscience, Osaka University School of Medicine, Osaka, Japan, the § Department of Molecular Biology, Princeton University, Princeton, New Jersey 08544, the ** Haldeman Laboratory for Alzheimer's Disease Research, Sun Health Research Institute, Sun City, Arizona 85372, and the Dagger Dagger  Department of Chemistry and Biochemistry, UCLA, Los Angeles, California 90024

Endoplasmic reticulum-associated amyloid beta -peptide (Abeta )-binding protein (ERAB)/L-3-hydroxyacyl-CoA dehydrogenase type II (HADH II) is expressed at high levels in Alzheimer's disease (AD)-affected brain, binds Abeta , and contributes to Abeta -induced cytotoxicity. Purified recombinant ERAB/HADH II catalyzed the NADH-dependent reduction of S-acetoacetyl-CoA with a Km of approx 68 µM and a Vmax of approx 430 µmol/min/mg. The contribution of ERAB/HADH II enzymatic activity to Abeta -mediated cellular dysfunction was studied by site-directed mutagenesis in the catalytic domain (Y168G/K172G). Although COS cells cotransfected to overexpress wild-type ERAB/HADH II and variant beta -amyloid precursor protein (beta APP(V717G)) showed DNA fragmentation, cotransfection with Y168G/K172G-altered ERAB and beta APP(V717G) was without effect. We thus asked whether the enzyme might recognize alcohol substrates of which the aldehyde products could be cytotoxic; ERAB/HADH II catalyzed oxidation of a variety of simple alcohols (C2-C10) to their respective aldehydes in the presence of NAD+ and NAD-dependent oxidation of 17beta -estradiol. Addition of micromolar levels of synthetic Abeta (1-40) to purified ERAB/HADH II inhibited, in parallel, reduction of S-acetoacetyl-CoA (Ki approx  1.6 µM), as well as oxidation of 17beta -estradiol (Ki approx 3.2 µM) and (-)-2-octanol (Ki approx  2.6 µM). Because micromolar levels of Abeta were required to inhibit ERAB/HADH II activity, whereas Abeta binding to ERAB/HADH II occurred at much lower concentrations (Km approx  40-70 nM), the latter more closely simulating Abeta levels within cells, Abeta perturbation of ERAB/HADH II was likely to result from mechanisms other than the direct modulation of enzymatic activity. Cells cotransfected to overexpress ERAB/HADH II and beta APP(V717G) generated malondialdehyde-protein and 4-hydroxynonenal-protein epitopes, which were detectable only at the lowest levels in cells overexpressing either ERAB/HADH II or beta APP(V717G) alone. Generation of such toxic aldehydes was not observed in cells contransfected to overexpress Y168G/K172G-altered ERAB and beta APP(V717G). We conclude that the generalized alcohol dehydrogenase activity of ERAB/HADH II is central to the cytotoxicity observed in an Abeta -rich environment.


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Y. Ren, H. W. Xu, F. Davey, M. Taylor, J. Aiton, P. Coote, F. Fang, J. Yao, D. Chen, J. X. Chen, et al.
Endophilin I Expression Is Increased in the Brains of Alzheimer Disease Patients
J. Biol. Chem., February 29, 2008; 283(9): 5685 - 5691.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
J. W. Lustbader, M. Cirilli, C. Lin, H. W. Xu, K. Takuma, N. Wang, C. Caspersen, X. Chen, S. Pollak, M. Chaney, et al.
ABAD Directly Links A{beta} to Mitochondrial Toxicity in Alzheimer's Disease
Science, April 16, 2004; 304(5669): 448 - 452.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
Y. Zhang, R. McLaughlin, C. Goodyer, and A. LeBlanc
Selective cytotoxicity of intracellular amyloid {beta} peptide1-42 through p53 and Bax in cultured primary human neurons
J. Cell Biol., February 4, 2002; 156(3): 519 - 529.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Morishima, Y. Gotoh, J. Zieg, T. Barrett, H. Takano, R. Flavell, R. J. Davis, Y. Shirasaki, and M. E. Greenberg
{beta}-Amyloid Induces Neuronal Apoptosis Via a Mechanism that Involves the c-Jun N-Terminal Kinase Pathway and the Induction of Fas Ligand
J. Neurosci., October 1, 2001; 21(19): 7551 - 7560.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
I. Greeve, I. Hermans-Borgmeyer, C. Brellinger, D. Kasper, T. Gomez-Isla, C. Behl, B. Levkau, and R. M. Nitsch
The Human DIMINUTO/DWARF1 Homolog Seladin-1 Confers Resistance to Alzheimer's Disease-Associated Neurodegeneration and Oxidative Stress
J. Neurosci., October 1, 2000; 20(19): 7345 - 7352.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. D. Yan, A. Roher, A. M. Schmidt, and D. M. Stern
Cellular Cofactors for Amyloid {beta}-Peptide-Induced Cell Stress : Moving from Cell Culture to in Vivo
Am. J. Pathol., November 1, 1999; 155(5): 1403 - 1411.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Du Yan, Y. Zhu, E. D. Stern, Y. C. Hwang, O. Hori, S. Ogawa, M. P. Frosch, E. S. Connolly Jr., R. McTaggert, D. J. Pinsky, et al.
Amyloid beta -Peptide-binding Alcohol Dehydrogenase Is a Component of the Cellular Response to Nutritional Stress
J. Biol. Chem., August 25, 2000; 275(35): 27100 - 27109.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
Y. Zhang, R. McLaughlin, C. Goodyer, and A. LeBlanc
Selective cytotoxicity of intracellular amyloid {beta} peptide1-42 through p53 and Bax in cultured primary human neurons
J. Cell Biol., February 4, 2002; 156(3): 519 - 529.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement